Showing results (41-50 of 902) with videos related to
Sort By:
Pageof 91
Pharmacotherapy|December 17, 1997
N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopeniaM D Combs, P J Perry, K A BeverAmerican Journal of Hospital Pharmacy|June 1, 1978
Anticholinergic psychosisP J Perry, D C Wilding, R P JuhlArchives of General Psychiatry|April 1, 1981
Side effects of corticosteroid therapy. Psychiatric aspectsM H Ling, P J Perry, M T TsuangArchives of General Psychiatry|September 1, 1977
Water intoxication, psychosis, and inappropriate secretion of antidiuretic hormoneR C Fowler, Z A Kronfol, P J PerryPharmacotherapy|December 22, 1999
Treatment of Parkinson's disease with ropinirole after pergolide-induced retroperitoneal fibrosisB C Lund, R F Neiman, P J PerryExpert Opinion on Investigational Drugs|January 5, 2002
Telomerase inhibitors for the treatment of cancer: the current perspectiveP J Perry, J R Arnold, T C JenkinsPharmacotherapy|June 13, 2001
Ziprasidone, a new atypical antipsychotic drugR M Carnahan, B C Lund, P J PerryDiseases of the Nervous System|September 1, 1977
Concomitant administration of haloperidol and lithium carbonate in acute maniaR P Juhl, M T Tsuang, P J PerryJournal of Clinical Psychopharmacology|February 1, 1988
The relationship of haloperidol concentrations to therapeutic responseP J Perry, B M Pfohl, M W KellyJournal of Clinical Psychopharmacology|February 24, 2001
Olanzapine plasma concentrations and clinical response: acute phase results of the North American Olanzapine TrialP J Perry, B C Lund, T Sanger, et al.Pageof 91